SE413025B - Forfarande for framstellning av nya 6,7-bensomorfanderivat - Google Patents

Forfarande for framstellning av nya 6,7-bensomorfanderivat

Info

Publication number
SE413025B
SE413025B SE7404277A SE7404277A SE413025B SE 413025 B SE413025 B SE 413025B SE 7404277 A SE7404277 A SE 7404277A SE 7404277 A SE7404277 A SE 7404277A SE 413025 B SE413025 B SE 413025B
Authority
SE
Sweden
Prior art keywords
benzomorphander
derivatives
procedure
preparing new
preparing
Prior art date
Application number
SE7404277A
Other languages
English (en)
Swedish (sv)
Inventor
K Kobayashi
T Fukumaru
H Mizote
S Inaba
H Yamamoto
Original Assignee
Sumitomo Chemical Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sumitomo Chemical Co filed Critical Sumitomo Chemical Co
Publication of SE413025B publication Critical patent/SE413025B/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D211/00Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/68Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
    • C07D211/70Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/04Centrally acting analgesics, e.g. opioids
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D221/00Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00
    • C07D221/02Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00 condensed with carbocyclic rings or ring systems
    • C07D221/22Bridged ring systems
    • C07D221/26Benzomorphans
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02PCLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00Technologies relating to chemical industry
    • Y02P20/50Improvements relating to the production of bulk chemicals
    • Y02P20/55Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pain & Pain Management (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biomedical Technology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Other In-Based Heterocyclic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
SE7404277A 1973-03-31 1974-03-29 Forfarande for framstellning av nya 6,7-bensomorfanderivat SE413025B (sv)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP48037333A JPS5817190B2 (ja) 1973-03-31 1973-03-31 シンキナ 4,5− ジアルキルベンゾモルフアンユウドウタイノセイホウ

Publications (1)

Publication Number Publication Date
SE413025B true SE413025B (sv) 1980-03-31

Family

ID=12494691

Family Applications (1)

Application Number Title Priority Date Filing Date
SE7404277A SE413025B (sv) 1973-03-31 1974-03-29 Forfarande for framstellning av nya 6,7-bensomorfanderivat

Country Status (19)

Country Link
US (1) US3961066A (no)
JP (1) JPS5817190B2 (no)
AT (1) AT335630B (no)
AU (1) AU475932B2 (no)
BE (1) BE813096A (no)
CA (1) CA1040629A (no)
CH (1) CH594628A5 (no)
CS (1) CS183732B2 (no)
DE (1) DE2415124A1 (no)
ES (1) ES424787A1 (no)
FI (1) FI56835C (no)
FR (1) FR2223043B1 (no)
GB (1) GB1460053A (no)
HU (1) HU169133B (no)
NL (1) NL7404411A (no)
NO (1) NO142713C (no)
SE (1) SE413025B (no)
SU (1) SU591141A3 (no)
ZA (1) ZA742013B (no)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4205171A (en) * 1976-01-12 1980-05-27 Sterling Drug Inc. Aminomethanobenzazocines and nitromethanobenzazocines
CN111978252A (zh) * 2019-05-21 2020-11-24 复旦大学 手性苯并吗吩烷类衍生物及其制备方法和在药学上的应用

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3639407A (en) * 1965-05-05 1972-02-01 Geigy Chem Corp Novel 1 2 3 4 5 6-hexahydro-6-phenyl-2 6-methano-3-benzazocines
US3833595A (en) * 1968-12-26 1974-09-03 Sumitomo Chemical Co 2-aroylalkyl benzomorphans
US3700734A (en) * 1969-01-23 1972-10-24 Merck & Co Inc 2{40 -hydroxy-2,3,5-trimethyl-6,7-benzomorphan
US3793332A (en) * 1972-05-22 1974-02-19 Sumitomo Chemical Co 2-cyano alkylbenzomorphan derivatives and salts thereof

Also Published As

Publication number Publication date
CA1040629A (en) 1978-10-17
FR2223043B1 (no) 1977-07-01
CS183732B2 (en) 1978-07-31
HU169133B (no) 1976-09-28
ZA742013B (en) 1975-03-26
US3961066A (en) 1976-06-01
NO142713C (no) 1980-10-01
FI56835B (fi) 1979-12-31
JPS49124069A (no) 1974-11-27
BE813096A (fr) 1974-09-30
NL7404411A (no) 1974-10-02
CH594628A5 (no) 1978-01-13
SU591141A3 (ru) 1978-01-30
AT335630B (de) 1977-03-25
NO142713B (no) 1980-06-23
JPS5817190B2 (ja) 1983-04-05
GB1460053A (en) 1976-12-31
NO741126L (no) 1974-10-01
AU475932B2 (en) 1976-09-09
FR2223043A1 (no) 1974-10-25
DE2415124A1 (de) 1974-10-10
ATA259274A (de) 1976-07-15
FI56835C (fi) 1980-04-10
AU6735274A (en) 1975-10-09
ES424787A1 (es) 1976-11-16

Similar Documents

Publication Publication Date Title
SE419981B (sv) Forfarande for framstellning av 1alfa-hydroxi-vitamin d-derivat
SE420201B (sv) Forfarande for framstellning av nya 7alfa-metoxicefalosporinderivat
SE435713B (sv) Forfarande for framstellning av 1,3-bensoxazoler
SE419750B (sv) Forfarande for framstellning av 6-acyl-2,4-dialkyl-2-hydroxicyklohexan-1,35-trion
SE420720B (sv) Forfarande for framstellning av 2,6-disubstuerade fenylaminoguanidinforeningar
SE424863B (sv) Analogiforfarande for framstellning av nya isokinolinderivat
SE420098B (sv) Forfarande for framstellning av linkomycinderivat
SE418497B (sv) Forfarande for framstellning av nya 2,6-disubstituerade 2-fenyliminoimidazolidiner
SE400074B (sv) Analogiforfarande for framstellning av nya tripeptider
SE419443B (sv) Forfarande for framstellning av nya 2,4 diamino-5-bensylpyrimidinderivat
SE420716B (sv) Forfarande for framstellning av nya 2-aminometyl-4,6-diahalogenofenolderivat
SE430065B (sv) Forfarande for framstellning av nya 7 alfa-metoxicefalosporinderivat
SE416053B (sv) Forfarande for framstellning av 7alfa-metylostr-4-en-3alfa, 17beta-diol
SE419444B (sv) Forfarande for framstellning av nya 2,4-diamino-5-bensylpyrimidinderivat
SE419543B (sv) Forfarande for framstellning av vissa angivna isokinolinderivat
NO138376C (no) Fremgangsmaate for fremstilling av 1-beta-d-ribofuranosyl-1, 2, 4-triazol-3-karboksamid
SE402105B (sv) Forfarande for framstellning av 2-amino-5-alkyl-1,3,4-tiadiazoler
SE419549B (sv) Forfarande for framstellning av nya 7-(cyanometylaryl)acetamidocefalospotinderivat
SE415100B (sv) Forfarande for framstellning av kinuklidin-kinolinderivat
SE401833B (sv) Forfarande for framstellnig av vissa angivna 1,2,4-friazolderivat
SE417966B (sv) Forfarande for framstellning av pyrimidinoaminometyl-ergolinderivat
SE413025B (sv) Forfarande for framstellning av nya 6,7-bensomorfanderivat
SE402920B (sv) Forfarande for framstellning av nya 21-alkylerade 16alfa, 17alfa-alkylidendioxi-pregn-4-en-3,20-dioner
SE410969B (sv) Forfarande for framstellning av nya alkylfenylbensopyranopyridiner
SE7409006L (sv) Forfarande for frasmtellning av nya bifenyl-derivat.